RxDoctor Payments Data

Karen Meckler, MD

Psychiatry · Columbia, MDNPI 1396800959

Payments from drug & device makers

$3,168in general payments, 2019–2025

Across 174 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$975
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$523
  • Johnson & Johnson$363
  • Otsuka America Pharmaceutical, Inc.$174
  • Teva Pharmaceuticals USA, Inc.$160
  • E.r. Squibb & Sons, L.L.C.$139
  • plus $834 from 11 others

What the payments were for

  • Food & beverage$3,06297%
  • Education$1073%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,168 in reported general payments places this provider in the 85th percentile of 851 psychiatry providers in Maryland.

See all psychiatry providers in Maryland

Medicare billing

Part B allowed, 2024
$183,815
Medicare patients
103
Services billed
1,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl22$80,670
Lurasidone Hcl44$10,623
Bupropion XlBupropion Hcl112$2,636
Quetiapine Fumarate123$2,090
Methylphenidate ErMethylphenidate Hcl17$1,818
Duloxetine Hcl104$1,746
Lamotrigine126$1,583
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine20$1,422
Clonazepam232$1,362
Trazodone Hcl95$1,239
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine70$1,227
Fluoxetine Hcl50$1,081
Gabapentin61$1,053
Aripiprazole85$906
Clozapine13$879

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$975$80,67022 claims
Almatica Pharma LLCSertraline Hcl$38$24642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 851 psychiatry providers in Maryland.

Other psychiatry in Columbia

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →